Entrepreneurs

Third Wave Technologies, a Madison-based research molecular diagnostics company, has received a $25 million line of credit from Deerfield Management. The additional capital will support the execution of long-range plans for the human papilloma virus and the hospital lab markets. ...

The high cost of developing prescription drugs has started a race to make pharmaceutical products more affordable, and venture capitalists are placing bets on the outcome. CDI Bioscience, a Madison-based company that has developed a technology to boost protein production and lower drug-manufacturing costs, will...

New distribution agreements signed by TomoTherapy will extend access to the company's cancer treatment technology to a greater percentage of the global marketplace. TomoTherapy has signed contracts with distributors in Israel, Greece, Poland, Turkey, Russia, and the United Arab Emirates. ...

UW-Madison Chancellor John D. Wiley, who has led Wisconsin's flagship university since 2001, has announced that he is stepping down as chancellor effective in September of 2008. Under Wiley's leadership, UW-Madison has risen to No. 2 nationally in terms of the amount of research conducted...

The non-statutory stock option, typically afforded executives in companies, has been the subject of the recent backdating scandals faced by a number of high-profile tech companies, noted legal columnist Sverre Roang. In this WTN Guest Column, Roang delves deeper into the “NSO” and explains why...

Could financial industry CIOs have better used IT to mitigate subprime exposure? The answer is yes, says columnist Patrick Gray, if the CIOs had expanded their definition of business intelligence. In this edition of Breakthrough IT, he states that simply building data repositories is not...

Admitting defeat is one of the most difficult things for human beings to do, and chief information officers are no different. Yet pulling the plug on failing information technology projects, before they become expensive mistakes, can bring benefits to the organization and the CIO, alike....

A team led by University of Wisconsin biologist Gabriela Cezar has used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease, according to a report in the journal Stem Cells and Development. By tuning in to...

BEST Energies and Sanimax Energy have announced they will join forces to bring Wisconsin's second largest biodiesel plant on-line before the end of 2007. BEST Energies is set to open a new 10 million gallon biodiesel plant in Cashton, while Sanimax will market all of...

ConjuGon has been awarded $1.2 million from the U.S. Department of Defense in 2008 to help fund the development of a new wound infection treatment product. The funds are included in the fiscal year 2008 defense appropriations bill, which was signed into law by President...